Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial

Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:28:43.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to a clinical trial for adult participants with schizophrenia comparing inpatient psychiatric hospitalization rates between standard-of-care antipsychotic treatment and Abilify MyCite®.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:52.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to include detailed eligibility criteria for participants, specifying requirements such as willingness to give informed consent, language proficiency, age range, smartphone usage, and specific health conditions. Previously, no information was provided for both collaborators and investigators.
    Difference
    16%
    Check dated 2024-05-22T21:24:34.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:35:26.000Z thumbnail image

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.